Quality and Safety in Hospital Pediatrics During COVID-19: A National Qualitative Study

Nadia Roessler De Angulo1, Nicole Penwill1, Priya R Pathak1

  • 1University of California, San Francisco, California.

Hospital Pediatrics
|December 23, 2021
PubMed

Insights

The coronavirus disease 2019 (COVID-19) pandemic created significant challenges in pediatric inpatient quality and safety. Key issues included disrupted clinical workflows, communication barriers, and operational strains, impacting patient care and safety outcomes.

Area of Science:

  • Pediatric Healthcare
  • Quality Improvement
  • Pandemic Preparedness

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic significantly disrupted healthcare systems globally.
  • Inpatient pediatric care faced unique challenges due to the pandemic's impact on clinical workflows and hospital operations.

Purpose of the Study:

  • To describe the challenges encountered in inpatient pediatric quality and safety during the COVID-19 pandemic.
  • To identify key areas for improvement in pediatric healthcare during and after public health crises.

Main Methods:

  • A qualitative study involving semistructured interviews with healthcare professionals and caregivers.
  • Participants were recruited from community and children's hospitals in high-COVID-19 hospitalization rate states.
  • Constant comparative methods were used to analyze interview data and identify themes.

Main Results:

  • Impacts on clinical workflows included reduced patient interactions and communication difficulties, partially mitigated by telehealth.
  • Hospital operations were affected by changes in quality monitoring, increased health risks for staff, and shortages of personnel and supplies.
  • Concerns were raised about increased risks of safety events, readmissions, and decreased patient satisfaction.

Conclusions:

  • The COVID-19 pandemic presented substantial challenges to inpatient pediatric quality and safety.
  • Findings underscore the need for focused strategies to manage pandemic-related disruptions and enhance future preparedness.
  • Further research is recommended to address quality and safety in pediatric inpatient settings during health crises.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
676
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
17
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15